121 related articles for article (PubMed ID: 38042247)
21. RUVBL1/2 Complex Regulates Pro-Inflammatory Responses in Macrophages
Zhang R; Cheung CY; Seo SU; Liu H; Pardeshi L; Wong KH; Chow LMC; Chau MP; Wang Y; Lee AR; Kwon WY; Chen S; Chan BK; Wong K; Choy RKW; Ko BCB
Front Immunol; 2021; 12():679184. PubMed ID: 34276666
[TBL] [Abstract][Full Text] [Related]
22. miR-944 acts as a prognostic marker and promotes the tumor progression in endometrial cancer.
He Z; Xu H; Meng Y; Kuang Y
Biomed Pharmacother; 2017 Apr; 88():902-910. PubMed ID: 28178620
[TBL] [Abstract][Full Text] [Related]
23. STAT1-induced upregulation of lncRNA LINC01123 predicts poor prognosis and promotes the progression of endometrial cancer through miR-516b/KIF4A.
Yang Y; Wu J; Zhou H; Liu W; Wang J; Zhang Q
Cell Cycle; 2020 Jun; 19(12):1502-1516. PubMed ID: 32401659
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of AHNAK2 inhibits cell cycle of lung adenocarcinoma cells by interacting with RUVBL1.
Li X; Li H; Shao MM; Miao J; Fu Y; Hu B
Thorac Cancer; 2023 Aug; 14(22):2093-2104. PubMed ID: 37349884
[TBL] [Abstract][Full Text] [Related]
25. Iroquois homeobox 2 suppresses cellular motility and chemokine expression in breast cancer cells.
Werner S; Stamm H; Pandjaitan M; Kemming D; Brors B; Pantel K; Wikman H
BMC Cancer; 2015 Nov; 15():896. PubMed ID: 26560478
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-505 functions as a tumor suppressor in endometrial cancer by targeting TGF-α.
Chen S; Sun KX; Liu BL; Zong ZH; Zhao Y
Mol Cancer; 2016 Feb; 15():11. PubMed ID: 26832151
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of TICRR and PPIF confer poor prognosis in endometrial cancer identified by gene co-expression network analysis.
Yang L; Cui Y; Sun X; Wang Y
Aging (Albany NY); 2021 Jan; 13(3):4564-4589. PubMed ID: 33495413
[TBL] [Abstract][Full Text] [Related]
28. Long noncoding RNA TUSC7 inhibits cell proliferation, migration and invasion by regulating SOCS4 (SOCS5) expression through targeting miR-616 in endometrial carcinoma.
Wu X; Cai D; Zhang F; Li M; Wan Q
Life Sci; 2019 Aug; 231():116549. PubMed ID: 31200002
[TBL] [Abstract][Full Text] [Related]
29. A TrkB-STAT3-miR-204-5p regulatory circuitry controls proliferation and invasion of endometrial carcinoma cells.
Bao W; Wang HH; Tian FJ; He XY; Qiu MT; Wang JY; Zhang HJ; Wang LH; Wan XP
Mol Cancer; 2013 Dec; 12():155. PubMed ID: 24321270
[TBL] [Abstract][Full Text] [Related]
30. Involvement of RUVBL1 in WNT/
Zeng Y; Kong Y; Liao L; Zhu H
Dis Markers; 2022; 2022():3398492. PubMed ID: 35493294
[TBL] [Abstract][Full Text] [Related]
31. miRNA-329-3p suppresses proliferation and metastasis of endometrial carcinoma through downregulating E2F1.
Wang R; Zhang C; Guan W; Yang Q
Neoplasma; 2023 Aug; 70(4):566-579. PubMed ID: 37789781
[TBL] [Abstract][Full Text] [Related]
32. LncRNA GATA3-AS1 promoted invasion and migration in human endometrial carcinoma by regulating the miR-361/ARRB2 axis.
Liu YX; Yuan S; Liu XJ; Huang YX; Qiu P; Gao J; Deng GP
J Mol Med (Berl); 2022 Sep; 100(9):1271-1286. PubMed ID: 35788718
[TBL] [Abstract][Full Text] [Related]
33. Integrated multi-omics analyses and functional validation reveal TTK as a novel EMT activator for endometrial cancer.
Miao Y; Konno Y; Wang B; Zhu L; Zhai T; Ihira K; Kobayashi N; Watari H; Jin X; Yue J; Dong P; Fang M
J Transl Med; 2023 Feb; 21(1):151. PubMed ID: 36829176
[TBL] [Abstract][Full Text] [Related]
34. IGF2BP1 overexpression stabilizes PEG10 mRNA in an m6A-dependent manner and promotes endometrial cancer progression.
Zhang L; Wan Y; Zhang Z; Jiang Y; Gu Z; Ma X; Nie S; Yang J; Lang J; Cheng W; Zhu L
Theranostics; 2021; 11(3):1100-1114. PubMed ID: 33391523
[No Abstract] [Full Text] [Related]
35. LncRNA MIR22HG negatively regulates miR-141-3p to enhance DAPK1 expression and inhibits endometrial carcinoma cells proliferation.
Cui Z; An X; Li J; Liu Q; Liu W
Biomed Pharmacother; 2018 Aug; 104():223-228. PubMed ID: 29775889
[TBL] [Abstract][Full Text] [Related]
36. CDK4/RB/E2Fs axis as potential therapeutic target of endometrial cancer.
Hu J; Shen J; Sun J
Biomed Pharmacother; 2020 May; 125():109870. PubMed ID: 32032891
[TBL] [Abstract][Full Text] [Related]
37. miR-142 Suppresses Endometrial Cancer Proliferation In Vitro and In Vivo by Targeting Cyclin D1.
Su Y; Wang J; Ma Z; Gong W; Yu L
DNA Cell Biol; 2019 Feb; 38(2):144-150. PubMed ID: 30585737
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-381 inhibits cell proliferation and invasion in endometrial carcinoma by targeting the IGF-1R.
Tu C; Wang F; Wan J
Mol Med Rep; 2018 Mar; 17(3):4090-4098. PubMed ID: 29257334
[TBL] [Abstract][Full Text] [Related]
39. Combined CRISPRi and proteomics screening reveal a cohesin-CTCF-bound allele contributing to increased expression of RUVBL1 and prostate cancer progression.
Tian Y; Dong D; Wang Z; Wu L; Park JY; ; Wei GH; Wang L
Am J Hum Genet; 2023 Aug; 110(8):1289-1303. PubMed ID: 37541187
[TBL] [Abstract][Full Text] [Related]
40. Knocking down of LINC01220 inhibits proliferation and induces apoptosis of endometrial carcinoma through silencing MAPK11.
Li Y; Kong C; Wu C; Wang Y; Xu B; Liang S; Ying X
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31123170
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
